MIRA INFORM REPORT

 

 

Report Date :

04.12.2013

 

IDENTIFICATION DETAILS

 

Name :

HORIBA, LTD.

 

 

Registered Office :

2, Miyanohigashi-cho, Kisshoin, Minami-ku, Kyoto-Shi, 601-8510

 

 

Country :

Japan

 

 

Financials (as on) :

31.12.2012

 

 

Date of Incorporation :

26.01.1953

 

 

Legal Form :

Public Parent

 

 

Line of Business :

Subject is engaged in the manufacture and sale of measuring equipment

 

 

No. of Employees :

5,530

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

No complaints

 

 

Litigation :

Clear

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March, 31st, 2013

 

Country Name

Previous Rating

(31.12.2012)

Current Rating

(31.03.2013)

Japan

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


 

JAPAN - ECONOMIC OVERVIEW

 

In the years following World War II, government-industry cooperation, a strong work ethic, mastery of high technology, and a comparatively small defense allocation (1% of GDP) helped Japan develop a technologically advanced economy. Two notable characteristics of the post-war economy were the close interlocking structures of manufacturers, suppliers, and distributors, known as keiretsu, and the guarantee of lifetime employment for a substantial portion of the urban labor force. Both features are now eroding under the dual pressures of global competition and domestic demographic change. Japan's industrial sector is heavily dependent on imported raw materials and fuels. A small agricultural sector is highly subsidized and protected, with crop yields among the highest in the world. While self-sufficient in rice production, Japan imports about 60% of its food on a caloric basis. For three decades, overall real economic growth had been spectacular - a 10% average in the 1960s, a 5% average in the 1970s, and a 4% average in the 1980s. Growth slowed markedly in the 1990s, averaging just 1.7%, largely because of the after effects of inefficient investment and an asset price bubble in the late 1980s that required a protracted period of time for firms to reduce excess debt, capital, and labor. Modest economic growth continued after 2000, but the economy has fallen into recession three times since 2008. A sharp downturn in business investment and global demand for Japan's exports in late 2008 pushed Japan into recession. Government stimulus spending helped the economy recover in late 2009 and 2010, but the economy contracted again in 2011 as the massive 9.0 magnitude earthquake and the ensuing tsunami in March disrupted manufacturing. The economy has largely recovered in the two years since the disaster, but reconstruction in the Tohoku region has been uneven. Newly-elected Prime Minister Shinzo ABE has declared the economy his government's top priority; he has pledged to reconsider his predecessor's plan to permanently close nuclear power plants and is pursuing an economic revitalization agenda of fiscal stimulus and regulatory reform and has said he will press the Bank of Japan to loosen monetary policy. Measured on a purchasing power parity (PPP) basis that adjusts for price differences, Japan in 2012 stood as the fourth-largest economy in the world after second-place China, which surpassed Japan in 2001, and third-place India, which edged out Japan in 2012. The new government will continue a longstanding debate on restructuring the economy and reining in Japan's huge government debt, which exceeds 200% of GDP. Persistent deflation, reliance on exports to drive growth, and an aging and shrinking population are other major long-term challenges for the economy.

 

Source : CIA

 


Company name & address


 

HORIBA, LTD.                                                                                                                                                                                                                                                                                                                                                               

 

 

2

Miyanohigashi-cho, Kisshoin, Minami-ku

 

Kyoto-Shi, 601-8510

Japan

 

 

Tel:

81-75-3138121

Fax:

81-75-3218312

 

 www.horiba.com

 

Employees:

5,530

Company Type:

Public Parent

Corporate Family:

49 Companies

Traded:

Tokyo Stock Exchange:

6856

Incorporation Date:

26-Jan-1953

Auditor:

KPMG AZSA LLC

Financials in:

               

 

 

Fiscal Year End:

31-Dec-2012

Reporting Currency:

Japanese Yen

Annual Sales:

1,473.8  1

Net Income:

92.7

Total Assets:

1,791.5  2

Market Value:

1,471.2

 

(08-Nov-2013)

 

 

Business Description     

 

 

HORIBA, Ltd. is a Japan-based company engaged in the manufacture and sale of measuring equipment. The Automotive Test System segment offers engine exhaust gas test systems, in-use automobile exhaust gas analyzers, in-car exhaust gas analyzers, drive-line test systems, engine test systems, brake test systems and drive recorders. The Environmental and Process System segment offers environmental test equipment and environmental radiometry equipment. The Medical System segment offers blood test equipment including blood cell counters, immunoassay systems, blood sugar test systems and others. The Semiconductor System segment provides mass flow controllers, chemical solution concentration monitors, semiconductor particle detection equipment and others. The Scientific System segment provides scientific test systems including proline hydroxylase (PH) meters, X-ray fluorescence instruments, spectrometers and others. For the nine months ended 30 September 2013, HORIBA, Ltd. revenues increased 11% to Y92.28B. Net income applicable to common stockholders increased 4% to Y4.22B. Revenues reflect Medical Equipment System segment increase of 20% to Y13.1B, Automotive Test Systems Equipment segment increase of 8% to Y20.32B, Semiconductor Instruments & Systems segment increase of 17% to Y9.95B.

 

 

Industry

 

 

Industry

Electromedical and Control Instruments Manufacturing

ANZSIC 2006:

2419 - Other Professional and Scientific Equipment Manufacturing

ISIC Rev 4:

2651 - Manufacture of measuring, testing, navigating and control equipment

NACE Rev 2:

2651 - Manufacture of instruments and appliances for measuring, testing and navigation

NAICS 2012:

334513 - Instruments and Related Products Manufacturing for Measuring, Displaying, and Controlling Industrial Process Variables

UK SIC 2007:

2651 - Manufacture of instruments and appliances for measuring, testing and navigation

US SIC 1987:

3823 - Industrial Instruments for Measurement, Display, and Control of Process Variables; and Related Products

 

 

Key Executives   

 

Name

Title

Jai Haku

Senior Managing Executive Officer, Chairman and President of Subsidiary

Bertrand De Castelnau

Executive Officer

Yutaka Kitsukawa

Managing Executive Officer, Chief Director of Finance

Masayuki Adachi

Managing Executive Officer, Chief Director of Promotion

Juichi Saito

Vice President, Chief Director of Business Strategy, Director

 

 

Significant Developments  

 

Topic

#*

Most Recent Headline

Date

Dividends

1

HORIBA Ltd to Issue Year-end Dividend for FY 2012

14-Feb-2013

Debt Ratings

1

R&I Affirms Rating on HORIBA Ltd at "A-"; Rating Outlook Stable

17-Jul-2013

 

 

* number of significant developments within the last 12 months    

            

 

News   

 

Title

Date

USPTO Published Patent application of HORIBA, Ltd. titled as "TEST SYSTEM". 
US Official News (249 Words)

3-Dec-2013

USPTO Published Patent application of HORIBA, Ltd. titled as "TEST SYSTEM AND VEHICLE PERFORMANCE TEST SYSTEM". 
US Official News (233 Words)

3-Dec-2013

US Patent Issued to Honda Motor on Dec. 3 for "Evaporated fuel treatment apparatus and method of detecting failure in control valve" (Japanese... 
U.S. Fed News (281 Words)

3-Dec-2013

Vehicle drivetrain test stand and method of controlling same
U.S. Patents (119 Words)

2-Dec-2013

Exhaust gas analyzing system
European Patents (131 Words)

2-Dec-2013

Exhaust gas analyzing apparatus, exhaust gas analyzing system and method of operating the same
European Patents (266 Words)

2-Dec-2013

 

Financial Summary

 

As of 30-Sep-2013

Key Ratios

Company

Industry

Current Ratio (MRQ)

2.18

3.16

Quick Ratio (MRQ)

1.58

1.74

Debt to Equity (MRQ)

0.18

0.29

Sales 5 Year Growth

-4.01

6.76

Net Profit Margin (TTM) %

5.93

8.43

Return on Assets (TTM) %

4.84

7.34

Return on Equity (TTM) %

7.58

12.34

 

              

Stock Snapshot

 

Traded: Tokyo Stock Exchange: 6856

 

As of 8-Nov-2013

   Financials in: JPY

Recent Price

3,410.00

 

EPS

179.54

52 Week High

4,050.00

 

Price/Sales

1.23

52 Week Low

2,155.00

 

Dividend Rate

43.00

Avg. Volume (mil)

0.17

 

Price/Earnings

20.61

Market Value (mil)

145,036.70

 

Price/Book

1.45

 

 

 

Beta

0.91

 

Price % Change

Rel S&P 500%

4 Week

-4.21%

-2.52%

13 Week

2.56%

-0.53%

52 Week

47.68%

-7.69%

Year to Date

37.00%

0.13%

 

 

Corporate Overview

 

Location
2
Miyanohigashi-cho, Kisshoin, Minami-ku
Kyoto-Shi, 601-8510
Japan

 

Tel:

81-75-3138121

Fax:

81-75-3218312

 

www.horiba.com

Quote Symbol - Exchange

6856 - Tokyo Stock Exchange

Sales JPY(mil):

117,609.0

Assets JPY(mil):

153,836.0

Employees:

5,530

Fiscal Year End:

31-Dec-2012

 

 

 

Industry:

Scientific and Technical Instruments

Incorporation Date:

26-Jan-1953

Company Type:

Public Parent

Quoted Status:

Quoted

 

Senior Managing Executive Officer, Chairman and President of Subsidiary:

Jai Haku

 


Industry Codes

 

ANZSIC 2006 Codes:

2419

-

Other Professional and Scientific Equipment Manufacturing

 

ISIC Rev 4 Codes:

2651

-

Manufacture of measuring, testing, navigating and control equipment

 

NACE Rev 2 Codes:

2651

-

Manufacture of instruments and appliances for measuring, testing and navigation

 

NAICS 2012 Codes:

334513

-

Instruments and Related Products Manufacturing for Measuring, Displaying, and Controlling Industrial Process Variables

334515

-

Instrument Manufacturing for Measuring and Testing Electricity and Electrical Signals

334516

-

Analytical Laboratory Instrument Manufacturing

334519

-

Other Measuring and Controlling Device Manufacturing

 

US SIC 1987:

3823

-

Industrial Instruments for Measurement, Display, and Control of Process Variables; and Related Products

3829

-

Measuring and Controlling Devices, Not Elsewhere Classified

3825

-

Instruments for Measuring and Testing of Electricity and Electrical Signals

3826

-

Laboratory Analytical Instruments

 

UK SIC 2007:

2651

-

Manufacture of instruments and appliances for measuring, testing and navigation

 

 

Business Description

 

HORIBA, Ltd. is a Japan-based company engaged in the manufacture and sale of measuring equipment. The Automotive Test System segment offers engine exhaust gas test systems, in-use automobile exhaust gas analyzers, in-car exhaust gas analyzers, drive-line test systems, engine test systems, brake test systems and drive recorders. The Environmental and Process System segment offers environmental test equipment and environmental radiometry equipment. The Medical System segment offers blood test equipment including blood cell counters, immunoassay systems, blood sugar test systems and others. The Semiconductor System segment provides mass flow controllers, chemical solution concentration monitors, semiconductor particle detection equipment and others. The Scientific System segment provides scientific test systems including proline hydroxylase (PH) meters, X-ray fluorescence instruments, spectrometers and others. For the nine months ended 30 September 2013, HORIBA, Ltd. revenues increased 11% to Y92.28B. Net income applicable to common stockholders increased 4% to Y4.22B. Revenues reflect Medical Equipment System segment increase of 20% to Y13.1B, Automotive Test Systems Equipment segment increase of 8% to Y20.32B, Semiconductor Instruments & Systems segment increase of 17% to Y9.95B.

 

 


More Business Descriptions

 

Manufacture of scientific, industrial and environmental analysers

 

Measuring Equipment Mfr & Sales

 

HORIBA, Ltd. (Horiba) is a medical device company. It carries out the manufacture and sale of measuring equipment. The company conducts its operations under four business divisions, namely, Automotive Test Systems, Process & Environmental Instruments & Systems, Medical-Diagnostic Instruments & Systems, Semiconductor Instruments & Systems and Scientific Instruments & Systems. The Automotive Test Systems provides various automotive test equipment; Process & Environmental Instruments & Systems division provides analytical equipment for scientific and environmental uses; Medical-Diagnostic Equipment division provides blood test equipment; and Semiconductor Instruments & Systems division offers mass flow controllers, chemical solution concentration monitors, measuring systems for semiconductor and liquid crystal films, semiconductor particle detection equipment and residual gas analyzers; and Scientific Instruments & Systems division provides elemental analysis, fluorescence, forensics, GDS, ICP, particle characterization, Raman, spectral ellipsometry, sulfur-in-oil, water quality, and XRF. The company has operations across Americas, Europe, Asia and Oceania. Horiba is headquartered in Minami-Ku, Japan.The company reported revenues of (Yen) JPY 117,609.00 million during the fiscal year ended December 2012, a decrease of 4.74% from 2011. The operating profit of the company was JPY 11,538.00 million during the fiscal year 2012, a decrease of 17.21% from 2011. The net profit of the company was JPY 7,396.00 million during the fiscal year 2012, a decrease of 14.65% from 2011.

 

Navigational, Measuring, Medical, and Control Instruments Manufacturing

 

 

Brand/Trade Names

 

Horiba

           

 

Financial Data

 

Financials in:

JPY(mil)

 

Revenue:

117,609.0

Net Income:

7,396.0

Assets:

153,836.0

Long Term Debt:

12,113.0

 

Total Liabilities:

54,342.0

 

Working Capital:

36.4

 

 

 

Date of Financial Data:

31-Dec-2012

 

1 Year Growth

-4.7%

-14.6%

6.4%

 

 


Market Data

 

Quote Symbol:

6856

Exchange:

Tokyo Stock Exchange

Currency:

JPY

Stock Price:

3,410.0

Stock Price Date:

11-08-2013

52 Week Price Change %:

47.7

Market Value (mil):

145,036,704.0

 

SEDOL:

6437947

ISIN:

JP3853000002

 

 

Equity and Dept Distribution

 

Up to FY'02 WAS were estimated. FY'04-'06: Q1 & Q3 WAS & O/S were estimated. FY End Changed from Mar.20. to Dec.31. from FY'06-'07 3Q & FY'08 1Q WAS & O/S were estimated. FY'08 Q2 reported BEPS=Y61.45, DEPS=Y61.40. FY'08 Q3 WAS was estimated and O/S=BWAS.

 

 

Subsidiaries

 

Company

Percentage Owned

Country

Horiba Jobin Yvon SAS

 

FRANCE

Horiba Europe GmbH

100%

GERMANY

 

 

Shareholders

 

 

Major Shareholders

Japan Trustee Services Bank (7.9%); Master Trust Bank of Japan (5.9%); Taiyo Fund LP (5.1%)

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                

 

Key Corporate Relationships

 

Auditor:

KPMG AZSA LLC

 

 

Auditor:

KPMG AZSA LLC

 

 

The Strategic Initiatives report is created using technology to extract meaningful insights from analyst reports about a company's strategic projects and investments. More about Strategic Initiatives

 

Strategic Initiatives

 

 

Sales and Distribution

Moreover, in July 2012, we introduced to the international market the MicrosemiCRP, compact product having a high market share in Japan. With the support of the prompt consumable supplies delivery system, we will promote sales of this new product in India; this will contribute to the development of medical practice in the country. International Expansion of Medical Business We have the reagent pant in Japan, France, China and Brazil. India will be our fifth production site. We have emphasized the expansion of regaent plants in emerging countries.  

89 per diluted share, for the same period of 2011.Jun 28, 2012Horiba To Release Automatic Blood Cell Counter And CRP Analyzer In Europe And Launch In IndiaHoriba, Ltd announced that in July 2012, it will begin sales of its flagship medical product, the Automatic Blood Cell Counter and CRP Analyzer, in Europe, and make a full-scale market entry in India with this product. The top-of-the-line model of compact diagnostic instruments, this is the only device in the world that can offer complete blood cell count (CBC) and CRP quantitative analysis simultaneously through patented technology.Horiba also said that it plans to release the Automatic Blood Cell Counter and CRP Analyzer in Korea, Thailand and other Asian countries, as well as in the Americas. The company also said that its goal is to sell a total of 3,000 units in overseas markets in the next five years.May 09, 2012Horiba Reports Revenue Of JPY29.5 Billion In Q1 2012Horiba, Ltd.  

 

 

Corporate Family

 

Total Corporate Family Members: 49 

 

Company Name

Company Type

Location

Country

Industry

Sales
(USD mil)

Employees

HORIBA, Ltd.

Parent

Kyoto-Shi

Japan

Electromedical and Control Instruments Manufacturing

1,473.8

5,530

Horiba Abx Sas

Subsidiary

Montpellier

France

Machinery and Equipment Manufacturing

168.4

673

Horiba Abx Sas Societe Par Actions Simplifiee

Subsidiary

Roma, Roma

Italy

Professional and Commercial Equipment Wholesale

 

 

HORIBA STEC, Co., Ltd.

Subsidiary

Kyoto

Japan

Semiconductor and Other Electronic Component Manufacturing

 

450

HORIBA STEC, Co., Ltd. - Aso Factory

Facility

Kumamoto, Aso-gun

Japan

Semiconductor and Other Electronic Component Manufacturing

 

 

Horiba Europe GmbH

Subsidiary

Oberursel (Taunus), Hessen

Germany

Electromedical and Control Instruments Manufacturing

172.8

400

Horiba Gmbh

Subsidiary

Tulln, Niederösterreich

Austria

Machinery Wholesale

9.0

 

HORIBA Europe GmbH - Leichlingen Facility

Unit

Leichlingen

Germany

Electromedical and Control Instruments Manufacturing

 

 

Horiba Jobin Yvon SAS

Subsidiary

Longjumeau

France

Electromedical and Control Instruments Manufacturing

111.0

297

HORIBA Jobin Yvon S.A.S. - Thin Film Division

Division

Paris

France

Electromedical and Control Instruments Manufacturing

 

50

HORIBA Jobin Yvon GmbH - Raman Division

Subsidiary

Unterhaching, Bayern

Germany

Electromedical and Control Instruments Manufacturing

18.3

45

Horiba Jobin Yvon SRL

Subsidiary

Orbassano

Italy

Miscellaneous Wholesale

4.2

15

HORIBA Jobin Yvon S.A.S. - Raman Division

Division

Villeneuve d'Ascq

France

Electromedical and Control Instruments Manufacturing

 

 

HORIBA Jobin Yvon Inc.

Subsidiary

Edison, NJ

United States

Electromedical and Control Instruments Manufacturing

 

175

HORIBA Advanced Techno Co., Ltd.

Subsidiary

Kyoto

Japan

Architecture and Engineering

 

150

HORIBA Advanced Techno Co., Ltd. - Kyoto Factory

Facility

Kyoto

Japan

Architecture and Engineering

 

140

HORIBA Instruments (Shanghai) Co., Ltd.

Subsidiary

Shanghai

China

Electromedical and Control Instruments Manufacturing

 

150

HORIBA Instruments Inc.- Ann Arbor Facility

Division

Ann Arbor, MI

United States

Electromedical and Control Instruments Manufacturing

 

100

HORIBA Trading (Shanghai) Co., Ltd.

Subsidiary

Shanghai

China

Machinery and Equipment Manufacturing

 

100

Horiba Instruments

Subsidiary

Northampton

United Kingdom

Electromedical and Control Instruments Manufacturing

24.8

96

Horiba Instruments Ltd.

UK Branch/Trading address

Northampton

United Kingdom

Electromedical and Control Instruments Manufacturing

24.8

75

HORIBA Instruments Inc. - Irvine Facility

Unit

Irvine, CA

United States

Electromedical and Control Instruments Manufacturing

 

80

HORIBA Medical

Subsidiary

Irvine, CA

United States

Medical Equipment and Supplies

 

55

Horiba Jobin Yvon Ibh Ltd

Subsidiary

Stanmore

United Kingdom

Electromedical and Control Instruments Manufacturing

 

10

HORIBA Instruments Inc

Branch

Spring, TX

United States

Machinery and Equipment Manufacturing

1.2

2

HORIBA Instruments Inc

Branch

Atlanta, GA

United States

Machinery and Equipment Manufacturing

0.6

2

HORIBA Instruments Inc

Branch

Coraopolis, PA

United States

Machinery and Equipment Manufacturing

0.3

1

HORIBA KOREA LTD. - Pucheon Facility

Unit

Bucheon, Kyunggi-do

Korea, Republic of

Semiconductor and Other Electronic Component Manufacturing

 

70

Horiba UK Ltd.

Subsidiary

Stanmore

United Kingdom

Electromedical and Control Instruments Manufacturing

12.7

50

HORIBA Europe Automation Division GmbH

Subsidiary

Neuhausen Auf Den Fildern, Baden-Württemberg

Germany

Electromedical and Control Instruments Manufacturing

 

50

HORIBA Automotive Test Systems Inc.

Subsidiary

Oakville, ON

Canada

Motor Vehicle Wholesale

14.5

45

HORIBA ABX Sp. Z. o.o.

Subsidiary

Warsaw

Poland

Motor Vehicle Repair and Maintenance

 

35

HORIBA France SARL

Subsidiary

Les Ulis

France

Electromedical and Control Instruments Manufacturing

23.3

34

Horiba Test Automation Ltd.

Subsidiary

Worcester

United Kingdom

Computer System Design Services

3.2

30

HORIBA Instruments (Singapore) PTE, Ltd.

Subsidiary

Singapore

Singapore

Architecture and Engineering

 

30

HORIBA India Private Ltd.

Subsidiary

New Delhi

India

Architecture and Engineering

 

30

HORIBA ABX Diagnostics Thailand Ltd.

Subsidiary

Bangkok

Thailand

Electromedical and Control Instruments Manufacturing

 

30

HORIBA GmbH

Subsidiary

Tulln

Austria

Electromedical and Control Instruments Manufacturing

 

25

HORIBA STEC Korea Ltd.

Subsidiary

Seongnam, Kyungki-do

Korea, Republic of

Semiconductor and Other Electronic Component Manufacturing

 

23

Horiba Stec Inc

Subsidiary

Santa Clara, CA

United States

Semiconductor and Other Electronic Component Manufacturing

 

20

Horiba Stec Inc

Branch

Austin, TX

United States

Semiconductor and Other Electronic Component Manufacturing

48.5

50

Horiba Stec Inc

Branch

Sparks, NV

United States

Semiconductor and Other Electronic Component Manufacturing

3.5

8

Horiba Stec Inc

Branch

Tigard, OR

United States

Semiconductor and Other Electronic Component Manufacturing

2.1

4

Horiba Stec Inc

Branch

Hudson, NH

United States

Semiconductor and Other Electronic Component Manufacturing

0.3

1

HORIBA Automotive Test Systems Ltd.

Subsidiary

Seoul

Korea, Republic of

Electromedical and Control Instruments Manufacturing

 

6

Horiba Instrument (Shanghai) Co., Ltd.

Subsidiary

Shanghai, Shanghai

China

Electromedical and Control Instruments Manufacturing

1.6

3

HORIBA Instruments Inc. - Tempe Facility

Unit

Tempe, AZ

United States

Electromedical and Control Instruments Manufacturing

 

 

HORIBA ABX Ltda.

Subsidiary

Sao Paulo

Brazil

Electromedical and Control Instruments Manufacturing

 

 

HORIBA Techno Service Co., Ltd.

Subsidiary

Kyoto

Japan

Architecture and Engineering

 

 

 

 

 

Competitors Report

 

CompanyName

Location

Employees

Ownership

Advanced Energy Industries, Inc.

Fort Collins, Colorado, United States

1,354

Public

KAINOS Laboratories, Inc.

Bunkyo-Ku, Japan

159

Public

MKS Instruments, Inc.

Andover, Massachusetts, United States

2,305

Public

Otsuka Pharmaceutical Co Ltd

Tokyo, Japan

5,701

Private

Unitika Ltd

Osaka-Shi, Japan

4,534

Public

 

 

Executives Report

 

Board of Directors

 

Name

Title

Function

 

Jai Haku

 

Senior Managing Executive Officer, Chairman and President of Subsidiary

Chairman

 

Atsushi Horiba

 

Chairman of the Board, President, President of Subsidiary, Representative Director

Chairman

 

Biography:

Mr. Atsushi Horiba has been serving as Chairman of the Board, President and Representative Director in HORIBA,Ltd., as well as President and Representative Director in a subsidiary, since June 2005. He is also serving as Representative Director in another company. He joined the Company in September 1972. His previous titles include Director of Overseas Technology, Chief Director of Overseas, Chief Director of Sales, Senior Managing Director and Chief Director of Production.

 

Age: 65

 

Education:

University of California , Irvine , Graduate School

 

Masahiro Sugita

 

Independent Director

Director/Board Member

 

 

Biography:

Mr. Masahiro Sugita has been serving as Independent Director in HORIBA, Ltd. since June 2006. He is also working for The 77 Bank and MSD K.K. He previously worked for the Bank of Japan and BANYU PHARMACEUTICAL CO., LTD.

 

Age: 68

 

 

 

Executives

 

Name

Title

Function

 

Jai Haku

 

Senior Managing Executive Officer, Chairman and President of Subsidiary

President

 

Michael Mariton

 

Managing Executive Officer, President of Subsidiary

President

 

Yuichi Muroga

 

Executive Officer, President of Subsidiary

Division Head Executive

 

 

Masayuki Adachi

 

Managing Executive Officer, Chief Director of Promotion

Managing Director

 

Kiyoaki Hara

 

Managing Executive Officer

Managing Director

 

Yutaka Kitsukawa

 

Managing Executive Officer, Chief Director of Finance

Managing Director

 

Takashi Nagano

 

Managing Executive Officer, Chief Director of Sales

Managing Director

 

Fumitoshi Sato

 

Managing Director, Chief Director of Administration, Manager of Tokyo Office

Managing Director

 

Biography:

Mr. Fumitoshi Sato has been serving as Managing Director, Chief Director of Administration and Manager of Tokyo Office in HORIBA, Ltd. since April 2008. He joined the Company in April 2004. He previously served as Managing Executive Officer and Manager of Group Supervision System Management Office. He used to work for the Bank of Japan prior to joining the Company.

 

Age: 59

 

Bertrand De Castelnau

 

Executive Officer

Senior Management (General)

 

Sunao Kikkawa

 

Senior Corporate Officer

Senior Management (General)

 

Hideyuki Koishi

 

Executive Officer

Senior Management (General)

 

Atsushi Nakamine

 

Executive Officer

Senior Management (General)

 

Juichi Saito

 

Vice President, Chief Director of Business Strategy, Director

Planning Executive

 

Biography:

Mr. Juichi Saito has been serving as Vice President, Chief Director of Business Strategy and Director in HORIBA, Ltd., since March 23, 2013. He joined the Company in March 1982. He previously served as Director of Engine Measurement Planning, Manager of Science and Semiconductor Business Strategy Office, Manager of Corporate Business Strategy Office and Development and Executive Officer. He used to serve as Vice President and Director in a subsidiary, as well as President and Representative Director in another America-based subsidiary.

 

Age: 55

 

Kozo Ishida

 

Vice President, Chief Director of Production, Representative Director

Manufacturing Executive

 

Biography:

Mr. Kozo Ishida has been serving as Vice President, Chief Director of Production and Representative Director in HORIBA,Ltd., effective January 2013. He is also serving as Director in a subsidiary. He joined the Company in March 1970. His previous titles include Senior Manager of Group Production Office, Director of 1st Product in Main Development and Sales Unit, Chief Director of Development, Managing Director, Senior Managing Director, Manager of Development Center and Senior Director of Engine Measurement System in the Company. He used to serve as President and Representative Director in a subsidiary and two other companies, as well as President, Chief Executive Officer and Representative Director in two subsidiaries.

 

Age: 68

 

Hiroshi Kawamura

 

Junior Corporate Officer

Other

 

 

 

Significant Developments

 

R&I Affirms Rating on HORIBA Ltd at "A-"; Rating Outlook Stable

Jul 17, 2013


Rating and Investment Information, Inc. (R&I) announced that it has affirmed the rating on Horiba Ltd. at "A-". The rating outlook is stable. 

HORIBA Ltd to Issue Year-end Dividend for FY 2012

Feb 14, 2013


HORIBA Ltd announced that it has decided to issue a year-end dividend payment of JPY 35 per share (JPY 1,480 million in total), above its latest dividend forecast of JPY 31 per share announced on November 6, 2012, to all its shareholders as a record of December 31, 2012. The dividend will be paid on March 4, 2013. 

 

 

News

 

 

USPTO Published Patent application of HORIBA, Ltd. titled as "TEST SYSTEM". 
US Official News (249 Words)

03-Dec-2013

USPTO Published Patent application of HORIBA, Ltd. titled as "TEST SYSTEM AND VEHICLE PERFORMANCE TEST SYSTEM". 
US Official News (233 Words)

03-Dec-2013

US Patent Issued to Honda Motor on Dec. 3 for "Evaporated fuel treatment apparatus and method of detecting failure in control valve" (Japanese... 
U.S. Fed News (281 Words)

03-Dec-2013

Vehicle drivetrain test stand and method of controlling same
U.S. Patents (119 Words)

02-Dec-2013

Exhaust gas analyzing system
European Patents (131 Words)

02-Dec-2013

Exhaust gas analyzing apparatus, exhaust gas analyzing system and method of operating the same
European Patents (266 Words)

02-Dec-2013

Test system and vehicle performance test system
European Patents (212 Words)

02-Dec-2013

Test system
European Patents (164 Words)

02-Dec-2013

Analyzer calibrating system and exhaust gas analyzing system
European Patents (157 Words)

02-Dec-2013

Exhaust gas analyzing apparatus
European Patents (246 Words)

02-Dec-2013

Horiba Instruments Assigned Patent
Targeted News Service (95 Words)

02-Dec-2013


Annual Income Statement

 

Financials in: USD (mil)

                     Except for share items (millions) and per share items (actual units)

 

Financial Glossary

 

 

 

 

 

31-Dec-2012

31-Dec-2011

31-Dec-2010

31-Dec-2009

31-Dec-2008

Period Length

12 Months

12 Months

12 Months

12 Months

12 Months

UpdateType/Date

Updated Normal 
31-Dec-2012

Reclassified Normal 
31-Dec-2012

Updated Normal 
31-Dec-2010

Updated Normal 
31-Dec-2009

Updated Normal 
31-Dec-2008

Filed Currency

JPY

JPY

JPY

JPY

JPY

Exchange Rate (Period Average)

79.797487

79.698224

87.789317

93.619712

103.395546

Auditor

KPMG AZSA LLC

KPMG LLP

KPMG LLP

KPMG LLP

KPMG LLP

Auditor Opinion

Unqualified

Unqualified

Unqualified

Unqualified with Explanation

Unqualified

 

 

 

 

 

 

    Net Sales

1,473.8

1,549.0

1,350.5

1,116.6

1,298.4

Revenue

1,473.8

1,549.0

1,350.5

1,116.6

1,298.4

Total Revenue

1,473.8

1,549.0

1,350.5

1,116.6

1,298.4

 

 

 

 

 

 

    Cost of Revenue

854.9

881.6

753.5

632.2

722.2

Cost of Revenue, Total

854.9

881.6

753.5

632.2

722.2

Gross Profit

618.9

667.5

596.9

484.4

576.2

 

 

 

 

 

 

    Selling/General/Administrative Expense

174.4

182.4

197.1

188.0

175.2

    Labor & Related Expense

170.8

171.8

151.7

141.5

155.2

    Advertising Expense

-

-

-

-

13.3

Total Selling/General/Administrative Expenses

345.2

354.2

348.8

329.5

343.8

Research & Development

126.5

126.2

108.0

105.0

103.1

    Depreciation

-

-

-

-

18.9

    Amortization of Acquisition Costs

-

-

-

-

4.4

Depreciation/Amortization

-

-

-

-

23.3

    Restructuring Charge

-

-

-

0.0

3.3

    Impairment-Assets Held for Use

3.5

1.8

1.7

2.9

5.4

    Impairment-Assets Held for Sale

0.0

4.6

2.3

0.3

1.8

    Other Unusual Expense (Income)

-0.8

5.7

4.1

1.2

-9.6

Unusual Expense (Income)

2.7

12.2

8.2

4.4

0.8

Total Operating Expense

1,329.3

1,374.2

1,218.5

1,071.1

1,193.2

 

 

 

 

 

 

Operating Income

144.6

174.9

132.0

45.5

105.2

 

 

 

 

 

 

        Interest Expense - Non-Operating

-6.0

-6.2

-5.6

-7.1

-8.6

    Interest Expense, Net Non-Operating

-6.0

-6.2

-5.6

-7.1

-8.6

        Interest Income - Non-Operating

2.9

1.4

1.3

1.8

3.3

        Investment Income - Non-Operating

-1.6

-2.6

1.2

1.8

-2.8

    Interest/Investment Income - Non-Operating

1.3

-1.2

2.5

3.6

0.5

Interest Income (Expense) - Net Non-Operating Total

-4.7

-7.4

-3.1

-3.5

-8.1

Gain (Loss) on Sale of Assets

0.4

0.1

3.3

0.0

0.3

    Other Non-Operating Income (Expense)

-0.3

3.7

3.2

5.0

-0.8

Other, Net

-0.3

3.7

3.2

5.0

-0.8

Income Before Tax

140.0

171.2

135.4

47.0

96.6

 

 

 

 

 

 

Total Income Tax

47.3

62.5

45.1

13.2

38.0

Income After Tax

92.7

108.7

90.3

33.8

58.6

 

 

 

 

 

 

    Minority Interest

0.0

0.0

0.0

0.0

-0.1

Net Income Before Extraord Items

92.7

108.7

90.3

33.8

58.5

Net Income

92.7

108.7

90.3

33.8

58.5

 

 

 

 

 

 

    Miscellaneous Earnings Adjustment

0.0

0.0

0.0

0.0

0.0

Total Adjustments to Net Income

0.0

0.0

0.0

0.0

0.0

Income Available to Common Excl Extraord Items

92.7

108.7

90.3

33.8

58.4

 

 

 

 

 

 

Income Available to Common Incl Extraord Items

92.7

108.7

90.3

33.8

58.4

 

 

 

 

 

 

Basic/Primary Weighted Average Shares

42.3

42.3

42.3

42.3

42.3

Basic EPS Excl Extraord Items

2.19

2.57

2.14

0.80

1.38

Basic/Primary EPS Incl Extraord Items

2.19

2.57

2.14

0.80

1.38

Dilution Adjustment

-

-

0.0

0.0

0.0

Diluted Net Income

92.7

108.7

90.3

33.8

58.4

Diluted Weighted Average Shares

42.4

42.4

42.4

42.3

42.3

Diluted EPS Excl Extraord Items

2.19

2.56

2.13

0.80

1.38

Diluted EPS Incl Extraord Items

2.19

2.56

2.13

0.80

1.38

Dividends per Share - Common Stock Primary Issue

0.50

0.50

0.19

0.14

0.43

Gross Dividends - Common Stock

26.5

21.2

8.2

5.9

18.0

Interest Expense, Supplemental

6.0

6.2

5.6

7.1

8.6

Depreciation, Supplemental

45.7

-

51.1

48.5

43.5

Total Special Items

3.5

12.1

5.3

4.8

5.0

Normalized Income Before Tax

143.5

183.3

140.7

51.8

101.5

 

 

 

 

 

 

Effect of Special Items on Income Taxes

0.8

4.4

1.6

1.2

0.2

Inc Tax Ex Impact of Sp Items

48.1

66.9

46.7

14.4

38.2

Normalized Income After Tax

95.4

116.4

94.0

37.3

63.3

 

 

 

 

 

 

Normalized Inc. Avail to Com.

95.4

116.4

93.9

37.3

63.1

 

 

 

 

 

 

Basic Normalized EPS

2.26

2.75

2.22

0.88

1.49

Diluted Normalized EPS

2.25

2.75

2.22

0.88

1.49

Amort of Acquisition Costs, Supplemental

1.2

-

0.4

0.4

4.4

Rental Expenses

-

-

-

-

19.0

Advertising Expense, Supplemental

-

-

-

-

13.3

Research & Development Exp, Supplemental

126.5

126.2

108.0

105.0

103.1

Reported Operating Profit

147.3

187.0

140.1

54.9

106.0

Reported Ordinary Profit

142.3

183.3

140.2

56.3

97.1

Normalized EBIT

147.3

187.0

140.1

49.9

106.0

Normalized EBITDA

194.2

187.0

191.6

98.8

153.9

    Current Tax - Total

40.6

65.1

-

-

-

Current Tax - Total

40.6

65.1

-

-

-

    Deferred Tax - Total

6.7

-2.6

-

-

-

Deferred Tax - Total

6.7

-2.6

-

-

-

Income Tax - Total

47.3

62.5

-

-

-

Interest Cost - Domestic

1.8

-

1.4

1.2

0.6

Service Cost - Domestic

10.6

-

8.4

12.3

14.7

Prior Service Cost - Domestic

1.5

-

1.3

1.2

1.1

Expected Return on Assets - Domestic

-0.9

-

-0.6

-0.6

-0.3

Actuarial Gains and Losses - Domestic

2.6

-

1.8

1.6

0.7

Other Pension, Net - Domestic

5.5

-

-

-

-

Domestic Pension Plan Expense

21.1

-

12.3

15.7

16.7

Defined Contribution Expense - Domestic

-

-

3.6

3.4

-

Total Pension Expense

21.1

-

15.8

19.1

16.7

Discount Rate - Domestic

2.00%

-

2.00%

2.00%

2.00%

Expected Rate of Return - Domestic

1.50%

-

1.50%

2.00%

2.00%

Total Plan Interest Cost

1.8

-

1.4

1.2

0.6

Total Plan Service Cost

10.6

-

8.4

12.3

14.7

Total Plan Expected Return

-0.9

-

-0.6

-0.6

-0.3

Total Plan Other Expense

5.5

-

-

-

-

 

 

Annual Balance Sheet

 

Financials in: USD (mil)

 

Financial Glossary

 

 

31-Dec-2012

31-Dec-2011

31-Dec-2010

31-Dec-2009

31-Dec-2008

UpdateType/Date

Updated Normal 
31-Dec-2012

Updated Normal 
31-Dec-2011

Updated Normal 
31-Dec-2010

Updated Normal 
31-Dec-2009

Updated Normal 
31-Dec-2008

Filed Currency

JPY

JPY

JPY

JPY

JPY

Exchange Rate

85.870003

76.94

81.105

93.095

90.65

Auditor

KPMG AZSA LLC

KPMG LLP

KPMG LLP

KPMG LLP

KPMG LLP

Auditor Opinion

Unqualified

Unqualified

Unqualified

Unqualified with Explanation

Unqualified

 

 

 

 

 

 

    Cash & Equivalents

403.9

375.5

332.4

231.2

201.5

    Short Term Investments

71.0

108.5

94.2

69.4

56.2

Cash and Short Term Investments

475.0

484.1

426.6

300.6

257.7

        Accounts Receivable - Trade, Gross

437.0

511.8

449.1

370.7

412.5

        Provision for Doubtful Accounts

-10.0

-9.7

-9.4

-8.9

-6.7

    Trade Accounts Receivable - Net

427.0

502.0

439.7

361.8

405.8

Total Receivables, Net

427.0

502.0

439.7

361.8

405.8

    Inventories - Finished Goods

117.6

117.2

102.8

83.9

111.5

    Inventories - Work In Progress

117.1

118.6

108.3

91.0

115.4

    Inventories - Raw Materials

92.5

105.8

95.2

76.1

101.8

Total Inventory

327.2

341.6

306.3

251.0

328.7

    Deferred Income Tax - Current Asset

33.6

41.6

36.1

22.3

26.4

    Other Current Assets

41.4

37.6

25.8

29.9

24.7

Other Current Assets, Total

75.0

79.2

61.9

52.3

51.1

Total Current Assets

1,304.2

1,407.0

1,234.5

965.7

1,043.3

 

 

 

 

 

 

Property/Plant/Equipment - Net

328.2

297.9

277.6

253.5

255.0

Goodwill, Net

3.7

2.6

2.6

3.1

3.7

Intangibles, Net

48.6

57.7

63.6

67.6

76.2

    LT Investment - Affiliate Companies

0.8

1.2

1.2

-

-

    LT Investments - Other

46.3

44.5

49.7

48.1

40.0

Long Term Investments

47.1

45.7

50.8

48.1

40.0

    Deferred Income Tax - Long Term Asset

23.6

27.5

26.2

23.8

22.3

    Other Long Term Assets

36.1

41.6

37.3

30.0

29.7

Other Long Term Assets, Total

59.8

69.1

63.6

53.8

51.9

Total Assets

1,791.5

1,879.9

1,692.7

1,391.8

1,470.2

 

 

 

 

 

 

Accounts Payable

137.8

171.5

166.3

113.5

122.5

Accrued Expenses

10.9

10.9

9.3

9.1

8.6

Notes Payable/Short Term Debt

64.3

80.0

62.2

71.1

97.7

Current Portion - Long Term Debt/Capital Leases

-

8.6

8.1

2.8

0.0

    Income Taxes Payable

15.3

32.0

42.6

7.2

16.7

    Other Payables

107.1

101.4

105.3

90.3

114.3

    Deferred Income Tax - Current Liability

0.1

0.2

0.4

0.3

0.1

    Other Current Liabilities

103.1

96.7

70.6

72.9

94.6

Other Current liabilities, Total

225.6

230.3

219.0

170.6

225.7

Total Current Liabilities

438.6

501.3

464.7

367.2

454.4

 

 

 

 

 

 

    Long Term Debt

141.1

146.8

138.0

126.0

133.8

    Capital Lease Obligations

-

3.3

2.9

3.1

-

Total Long Term Debt

141.1

150.0

141.0

129.1

133.8

Total Debt

205.4

238.6

211.2

202.9

231.5

 

 

 

 

 

 

    Deferred Income Tax - LT Liability

1.8

1.4

1.4

0.3

0.1

Deferred Income Tax

1.8

1.4

1.4

0.3

0.1

Minority Interest

0.5

0.5

0.1

0.1

0.1

    Reserves

5.3

8.0

6.1

0.6

0.6

    Pension Benefits - Underfunded

26.3

25.9

24.4

20.7

28.3

    Other Long Term Liabilities

19.3

17.5

17.4

14.9

5.2

Other Liabilities, Total

50.9

51.5

48.0

36.2

34.1

Total Liabilities

632.8

704.7

655.2

532.9

622.6

 

 

 

 

 

 

    Common Stock

139.9

156.1

148.1

129.0

132.4

Common Stock

139.9

156.1

148.1

129.0

132.4

Additional Paid-In Capital

220.8

245.7

232.3

201.7

206.4

Retained Earnings (Accumulated Deficit)

835.3

861.4

720.9

548.8

546.5

Treasury Stock - Common

-9.1

-10.2

-9.9

-8.7

-8.9

Unrealized Gain (Loss)

11.5

9.3

11.1

10.0

5.1

    Translation Adjustment

-39.7

-87.1

-65.0

-21.9

-34.0

    Other Equity

0.0

-

-

-

-

Other Equity, Total

-39.7

-87.1

-65.0

-21.9

-34.0

Total Equity

1,158.7

1,175.2

1,037.5

859.0

847.5

 

 

 

 

 

 

Total Liabilities & Shareholders’ Equity

1,791.5

1,879.9

1,692.7

1,391.8

1,470.1

 

 

 

 

 

 

    Shares Outstanding - Common Stock Primary Issue

42.3

42.3

42.3

42.3

42.3

Total Common Shares Outstanding

42.3

42.3

42.3

42.3

42.3

Treasury Shares - Common Stock Primary Issue

0.2

0.2

0.2

0.2

0.2

Employees

5,530

5,448

5,202

5,133

5,146

Number of Common Shareholders

6,577

7,883

7,407

7,798

8,856

Total Long Term Debt, Supplemental

155.3

153.7

21.3

130.9

141.0

Long Term Debt Maturing within 1 Year

14.2

6.9

6.6

4.9

7.2

Long Term Debt Maturing in Year 2

121.9

12.1

4.4

4.6

5.2

Long Term Debt Maturing in Year 3

5.1

132.0

9.7

4.2

4.2

Long Term Debt Maturing in Year 4

3.1

1.7

0.6

9.7

4.3

Long Term Debt Maturing in Year 5

2.6

1.0

0.0

107.4

9.8

Long Term Debt Maturing in 2-3 Years

127.0

144.1

14.1

8.9

9.4

Long Term Debt Maturing in 4-5 Years

5.8

2.6

0.6

117.1

14.1

Long Term Debt Matur. in Year 6 & Beyond

8.3

0.0

0.0

0.0

110.3

Total Capital Leases, Supplemental

5.2

4.9

4.4

5.9

-

Capital Lease Payments Due in Year 1

1.9

1.7

1.5

2.8

-

Capital Lease Payments Due in Year 2

1.5

1.5

1.2

1.2

-

Capital Lease Payments Due in Year 3

1.0

1.0

1.1

0.8

-

Capital Lease Payments Due in Year 4

0.7

0.5

0.5

0.8

-

Capital Lease Payments Due in Year 5

0.1

0.2

0.1

0.2

-

Capital Lease Payments Due in 2-3 Years

2.4

2.6

2.3

2.1

-

Capital Lease Payments Due in 4-5 Years

0.8

0.7

0.6

1.0

-

Cap. Lease Pymts. Due in Year 6 & Beyond

0.0

0.0

0.0

0.0

-

Pension Obligation - Domestic

74.9

75.8

67.9

56.4

53.5

Plan Assets - Domestic

49.4

42.6

36.5

27.5

22.6

Funded Status - Domestic

-25.5

-33.1

-31.4

-28.9

-30.8

Total Funded Status

-25.5

-33.1

-31.4

-28.9

-30.8

Discount Rate - Domestic

2.00%

2.00%

2.00%

2.00%

2.00%

Expected Rate of Return - Domestic

1.50%

1.50%

1.50%

2.00%

2.00%

Accrued Liabilities - Domestic

-24.1

-15.3

-21.4

-18.0

-18.4

Other Assets, Net - Domestic

1.4

10.1

10.0

10.9

12.3

Net Assets Recognized on Balance Sheet

-22.6

-5.2

-11.3

-7.1

-6.1

Total Plan Obligations

74.9

75.8

67.9

56.4

53.5

Total Plan Assets

49.4

42.6

36.5

27.5

22.6

 

 

Annual Cash Flows

 

Financials in: USD (mil)

 

Financial Glossary

 

Period Length

12 Months

12 Months

12 Months

12 Months

12 Months

UpdateType/Date

Updated Normal 
31-Dec-2012

Updated Normal 
31-Dec-2011

Updated Normal 
31-Dec-2010

Updated Normal 
31-Dec-2009

Updated Normal 
31-Dec-2008

Filed Currency

JPY

JPY

JPY

JPY

JPY

Exchange Rate (Period Average)

79.797487

79.698224

87.789317

93.619712

103.395546

Auditor

KPMG AZSA LLC

KPMG LLP

KPMG LLP

KPMG LLP

KPMG LLP

Auditor Opinion

Unqualified

Unqualified

Unqualified

Unqualified with Explanation

Unqualified

 

 

 

 

 

 

Net Income/Starting Line

140.0

171.2

135.3

46.9

96.5

    Depreciation

45.7

51.6

51.1

48.5

43.5

Depreciation/Depletion

45.7

51.6

51.1

48.5

43.5

    Amortization of Acquisition Costs

1.2

0.4

0.4

0.4

4.4

Amortization

1.2

0.4

0.4

0.4

4.4

    Accounting Change

-

-

-

-

0.0

    Unusual Items

3.1

6.4

0.8

3.1

-4.7

    Other Non-Cash Items

0.7

7.7

13.1

1.6

7.3

Non-Cash Items

3.9

14.1

13.9

4.7

2.7

    Accounts Receivable

51.8

-51.2

-56.8

38.2

27.7

    Inventories

0.5

-26.9

-42.0

72.0

-2.6

    Accounts Payable

-29.4

0.9

44.8

-8.2

-24.2

    Other Operating Cash Flow

-45.8

-73.0

-10.5

-56.1

-75.2

Changes in Working Capital

-22.9

-150.2

-64.5

45.9

-74.4

Cash from Operating Activities

167.9

87.2

136.2

146.4

72.7

 

 

 

 

 

 

    Purchase of Fixed Assets

-84.5

-52.7

-37.4

-42.1

-46.4

    Purchase/Acquisition of Intangibles

-8.9

-2.8

-2.1

-5.2

-13.8

Capital Expenditures

-93.4

-55.6

-39.5

-47.3

-60.2

    Sale of Fixed Assets

1.0

0.6

6.9

3.0

2.2

    Sale/Maturity of Investment

62.1

18.3

15.3

8.9

72.9

    Purchase of Investments

-70.4

-38.3

-15.1

-8.7

-10.0

    Other Investing Cash Flow

1.8

-2.1

0.2

-0.7

-0.1

Other Investing Cash Flow Items, Total

-5.5

-21.5

7.4

2.5

64.9

Cash from Investing Activities

-98.9

-77.1

-32.1

-44.8

4.8

 

 

 

 

 

 

    Other Financing Cash Flow

0.0

0.4

0.0

0.0

0.0

Financing Cash Flow Items

0.0

0.4

0.0

0.0

0.0

    Cash Dividends Paid - Common

-24.3

-10.6

-6.3

-15.8

-18.0

Total Cash Dividends Paid

-24.3

-10.6

-6.3

-15.8

-18.0

        Sale/Issuance of Common

-

-

-

-

0.0

        Repurchase/Retirement of Common

-

-

0.0

0.0

-7.7

    Common Stock, Net

0.0

-

0.0

0.0

-7.7

Issuance (Retirement) of Stock, Net

0.0

-

0.0

0.0

-7.7

    Short Term Debt, Net

-30.0

19.5

-0.4

-23.0

33.7

        Long Term Debt Issued

22.9

10.3

3.9

0.3

9.8

        Long Term Debt Reduction

-9.9

-8.9

-8.9

-11.9

-55.9

    Long Term Debt, Net

13.0

1.4

-5.0

-11.5

-46.1

Issuance (Retirement) of Debt, Net

-17.0

20.9

-5.4

-34.6

-12.4

Cash from Financing Activities

-41.4

10.8

-11.7

-50.4

-38.1

 

 

 

 

 

 

Foreign Exchange Effects

11.2

-4.5

-14.2

1.4

-19.1

Net Change in Cash

38.7

16.4

78.2

52.7

20.3

 

 

 

 

 

 

Net Cash - Beginning Balance

448.2

432.4

314.3

242.0

198.9

Net Cash - Ending Balance

487.0

448.8

392.5

294.7

219.2

Cash Interest Paid

6.3

6.5

5.7

7.5

8.1

Cash Taxes Paid

61.1

78.7

13.0

28.4

62.8

 

 

Annual Income Statement

 

Financials in: USD (mil)

Except for share items (millions) and per share items (actual units)

 

 

 

31-Dec-2012

31-Dec-2011

31-Dec-2010

31-Dec-2009

31-Dec-2008

Period Length

12 Months

12 Months

12 Months

12 Months

12 Months

UpdateType/Date

Updated Normal 
31-Dec-2012

Reclassified Normal 
31-Dec-2012

Updated Normal 
31-Dec-2010

Updated Normal 
31-Dec-2009

Updated Normal 
31-Dec-2008

Filed Currency

JPY

JPY

JPY

JPY

JPY

Exchange Rate (Period Average)

79.797487

79.698224

87.789317

93.619712

103.395546

Auditor

KPMG AZSA LLC

KPMG LLP

KPMG LLP

KPMG LLP

KPMG LLP

Auditor Opinion

Unqualified

Unqualified

Unqualified

Unqualified with Explanation

Unqualified

 

 

 

 

 

 

    Net sales

1,473.8

1,549.0

1,350.5

1,116.6

1,298.4

Total Revenue

1,473.8

1,549.0

1,350.5

1,116.6

1,298.4

 

 

 

 

 

 

    Cost of sales

854.9

881.6

753.5

627.1

722.2

    Other Selling, general and administrativ

173.6

181.1

-

-

-

    Depreciation

-

-

-

-

18.9

    Payroll

150.6

151.4

139.7

129.8

139.8

    Research & Development

126.5

126.2

108.0

105.0

103.1

    Periodic Retirement Benefit

8.9

8.3

7.0

8.6

8.8

    Amortization Goodwill

-

-

-

-

4.4

    Allowance for Bonus

6.3

6.5

3.3

2.5

5.5

    Allowance for Director Retirement B'fit

0.5

0.5

0.5

0.6

0.7

    Allowance for Doubtful Account

0.8

1.3

2.4

1.7

0.1

    Allowance for Director Bonus

4.4

5.1

1.2

0.1

0.4

    Advertising Expenses

-

-

-

-

13.3

    Sales Commission

-

-

-

-

12.9

    Travel

-

-

-

-

21.1

    Rental Expenses

-

-

-

-

19.0

    Freight Cost

-

-

-

-

23.5

    Other SG&A Expenses

-

-

194.7

186.3

98.6

    Other

0.0

0.0

-

-

-

    Rounding adjustment Income Statement

0.0

-

-

-

-

    Other Unusual Expense (Income)

-

0.0

-

-

-

    Reversal of provision for compensation l

-0.8

0.0

-

-

-

    SP Rev. G on lawsuit losses

-

-

-

0.0

-10.9

    SP Insurance cancel.income

-

-

-

0.0

-2.4

    SP Rev. of allow. for doubtful acc.

-

-

-0.2

0.0

-

    SP Reserve for debts guarantees

-

-

0.1

0.0

0.0

    SP Rev. Res. for debts guarantees

0.0

-0.8

0.0

-

-

    SP Other Special Gains

-

-

-

0.0

-0.1

    SP Write Off Fixed Assets L.

1.8

0.6

1.3

0.4

0.9

    SP Prov. for litigation losses

-

-

-

-

0.0

    SP Loss on Accounting Changes

-

-

-

-

0.0

    SP Impairment Loss

1.7

1.2

0.5

2.5

4.5

    SP Restructuring Exp.-Subs.

-

-

-

0.0

2.0

    SP Loss-Valuation of Inv. Secs.

0.0

4.6

2.3

0.1

1.8

    SP Antitrust law related losses

-

-

-

0.0

1.7

    SP Allow. Prior Directors' Benefits

-

-

-

0.0

1.4

    SP L US business reorganization

-

-

-

0.0

1.3

    SP L on val. of inventories

-

-

0.0

5.0

0.0

    Provision for compensation losses

0.0

2.7

3.4

0.0

-

    SP Prov. business structure improv.

0.0

3.4

0.0

-

-

    SP L on valuation of affiliated sec.

-

-

0.0

0.2

0.0

    SP Accrued Retirement

-

-

0.0

1.2

0.0

    SP Provision for doubtful accounts

-

-

-

-

0.7

    SP Office transfer expenses

0.0

0.5

0.8

0.0

-

    SP Other Special Loss

-

-

0.0

0.0

0.0

    NOP Loss- Valuation of Inventories

-

-

-

-

0.0

    NOP Loss- Retire. of Inventories

-

-

-

-

0.0

Total Operating Expense

1,329.3

1,374.2

1,218.5

1,071.1

1,193.2

 

 

 

 

 

 

    SP Gain-Sale Fixed Assets

0.4

0.1

3.6

0.1

0.3

    Loss on sales of investment securities

0.0

0.0

-

-

-

    SP Gain-Sale Inv. Secs.

-

-

0.1

0.1

0.0

    SP Loss-Sale Fixed Assets

0.0

-0.1

-0.3

-0.1

-0.1

    SP Loss-Sale Inv. Secs.

-

-

0.0

0.0

-

    NOP Interest Income

2.9

1.4

1.3

1.8

3.3

    NOP Dividend Income

1.0

1.0

0.8

0.8

1.0

    NOP Exchange Gain

-

-

0.4

1.0

0.0

    Other Non-Operating Income (Expense)

0.0

0.0

-

-

-

    NOP Subsidy Income

-

-

0.0

1.1

0.0

    NOP Other Income

3.2

4.5

4.3

5.4

5.0

    NOP Interest Expense

-6.0

-6.2

-5.6

-7.1

-8.6

    NOP Exchange Loss

-2.6

-3.6

0.0

0.0

-3.8

    NOP Other Expenses

-3.6

-0.8

-1.1

-1.5

-5.8

Net Income Before Taxes

140.0

171.2

135.4

47.0

96.6

 

 

 

 

 

 

Income taxes-current

47.3

62.5

45.1

13.2

38.0

Net Income After Taxes

92.7

108.7

90.3

33.8

58.6

 

 

 

 

 

 

    Minority interests in loss

0.0

0.0

-

-

-

    Minority Interest

-

-

0.0

0.0

-0.1

Net Income Before Extra. Items

92.7

108.7

90.3

33.8

58.5

Net Income

92.7

108.7

90.3

33.8

58.5

 

 

 

 

 

 

    Balancing item

-

0.0

-

-

-

    Miscellaneous Earnings Adjustment

0.0

-

-

-

-

    Adjustment

-

-

0.0

0.0

0.0

Income Available to Com Excl ExtraOrd

92.7

108.7

90.3

33.8

58.4

 

 

 

 

 

 

Income Available to Com Incl ExtraOrd

92.7

108.7

90.3

33.8

58.4

 

 

 

 

 

 

Basic Weighted Average Shares

42.3

42.3

42.3

42.3

42.3

Basic EPS Excluding ExtraOrdinary Items

2.19

2.57

2.14

0.80

1.38

Basic EPS Including ExtraOrdinary Items

2.19

2.57

2.14

0.80

1.38

Dilution Adjustment

-

-

0.0

0.0

0.0

Diluted Net Income

92.7

108.7

90.3

33.8

58.4

Diluted Weighted Average Shares

42.4

42.4

42.4

42.3

42.3

Diluted EPS Excluding ExtraOrd Items

2.19

2.56

2.13

0.80

1.38

Diluted EPS Including ExtraOrd Items

2.19

2.56

2.13

0.80

1.38

DPS-Ordinary Shares

0.50

0.50

0.19

0.14

0.43

Gross Dividends - Common Stock

26.5

21.2

8.2

5.9

18.0

Normalized Income Before Taxes

143.5

183.3

140.7

51.8

101.5

 

 

 

 

 

 

Inc Tax Ex Impact of Sp Items

48.1

66.9

46.7

14.4

38.2

Normalized Income After Taxes

95.4

116.4

94.0

37.3

63.3

 

 

 

 

 

 

Normalized Inc. Avail to Com.

95.4

116.4

93.9

37.3

63.1

 

 

 

 

 

 

Basic Normalized EPS

2.26

2.75

2.22

0.88

1.49

Diluted Normalized EPS

2.25

2.75

2.22

0.88

1.49

SGATotal Search And Development Expense

-

126.2

-

-

-

R&D (SGA)

126.5

-

108.0

105.0

103.1

Interest Expense

6.0

6.2

5.6

7.1

8.6

BC - Depreciation of Goodwill

1.2

-

-

-

-

Amort of Goodwill

-

-

0.4

0.4

4.4

Advertising Expenses

-

-

-

-

13.3

Rental Expenses

-

-

-

-

19.0

Depreciation

45.7

-

51.1

48.5

43.5

    Income taxes-current

40.6

65.1

-

-

-

Current Tax - Total

40.6

65.1

-

-

-

    Income taxes-deferred

6.7

-2.6

-

-

-

Deferred Tax - Total

6.7

-2.6

-

-

-

Income Tax - Total

47.3

62.5

-

-

-

Reported Operating Profit

147.3

187.0

140.1

54.9

106.0

Reported Ordinary Profit

142.3

183.3

140.2

56.3

97.1

Retirement Benefit Expenses Other

5.5

-

-

-

-

Service Cost

10.6

-

8.4

12.3

14.7

Interest Cost

1.8

-

1.4

1.2

0.6

Expected Return on Plan Assets

-0.9

-

-0.6

-0.6

-0.3

Actuarial Gains & Losses

2.6

-

1.8

1.6

0.7

Prior Service Cost

1.5

-

1.3

1.2

1.1

Domestic Pension Plan Expense

21.1

-

12.3

15.7

16.7

Defined Contriution Expense

-

-

3.6

3.4

-

Total Pension Expense

21.1

-

15.8

19.1

16.7

Discount Rate(MIN)-Domestic

2.00%

-

-

-

-

Discount Rate

-

-

2.00%

2.00%

2.00%

Expected return on assets(MIN)-Domestic

1.50%

-

-

-

-

Expected Rate of Return

-

-

1.50%

2.00%

2.00%

 

 

Annual Balance Sheet

 

Financials in: USD (mil)

 

 

 

 

31-Dec-2012

31-Dec-2011

31-Dec-2010

31-Dec-2009

31-Dec-2008

UpdateType/Date

Updated Normal 
31-Dec-2012

Updated Normal 
31-Dec-2011

Updated Normal 
31-Dec-2010

Updated Normal 
31-Dec-2009

Updated Normal 
31-Dec-2008

Filed Currency

JPY

JPY

JPY

JPY

JPY

Exchange Rate

85.870003

76.94

81.105

93.095

90.65

Auditor

KPMG AZSA LLC

KPMG LLP

KPMG LLP

KPMG LLP

KPMG LLP

Auditor Opinion

Unqualified

Unqualified

Unqualified

Unqualified with Explanation

Unqualified

 

 

 

 

 

 

    Cash & Deposit

403.9

375.5

332.4

231.2

201.5

    Notes and accounts receivable-trade

437.0

511.8

449.1

370.7

412.5

    Short-term investment securities

71.0

108.5

94.2

69.4

56.2

    Merchandise & finished goods.

117.6

117.2

102.8

83.9

111.5

    Work in process

117.1

118.6

108.3

91.0

115.4

    Raw materials & supplies

92.5

105.8

95.2

76.1

101.8

    Dfrd Tax Assets

33.6

41.6

36.1

22.3

26.4

    Rounding adjustment Assets

0.0

-

-

-

-

    Other Cur. Asset

41.4

37.6

25.8

29.9

24.7

    Doubtful Account

-10.0

-9.7

-9.4

-8.9

-6.7

Total current assets

1,304.2

1,407.0

1,234.5

965.7

1,043.3

 

 

 

 

 

 

    Other total ppe

0.0

-

-

-

-

    Buildings and structures, net

138.5

106.0

106.7

103.2

83.3

    Machinery Equipment And Vehicles

36.9

38.3

40.6

42.8

40.4

    Land

95.2

95.7

89.7

76.8

78.8

    Construction IP

21.6

27.7

9.2

1.7

19.0

    Other

36.0

30.3

31.5

29.0

33.5

    Goodwill

3.7

2.6

2.6

3.1

3.7

    Other Total intangible assets

0.0

-

-

-

-

    Software

40.6

54.4

59.0

61.5

67.5

    Other Intangible

7.9

3.3

4.6

6.0

8.7

    Invt Secs Noncons, Asc, Affd Cos

0.8

-

-

-

-

    Equity secs.-nonconsolidated affil.

-

1.2

1.2

-

-

    Other Investment Securities

46.3

-

-

-

-

    Investment Secs.

-

44.5

49.7

48.1

40.0

    Rounding adjustment Assets

0.0

-

-

-

-

    Other Total investments and other assets

0.0

-

-

-

-

    Deferred tax assets

23.6

27.5

26.2

23.8

22.3

    Other Assets

37.0

42.1

39.8

31.4

30.7

    Doubtful Account

-0.9

-0.5

-2.5

-1.4

-1.0

Total Assets

1,791.5

1,879.9

1,692.7

1,391.8

1,470.2

 

 

 

 

 

 

    Notes and accounts payable-trade

137.8

171.5

166.3

113.5

122.5

    Short-term loans payable

64.3

80.0

62.2

71.1

97.7

    Current Portion of LT Debt

-

6.9

6.6

-

0.0

    Fin.Lease current

-

1.7

1.5

2.8

-

    Accounts payable-other

107.1

101.4

105.3

90.3

114.3

    Corporate Tax Payable

15.3

32.0

42.6

7.2

16.7

    Deferred Tax

0.1

0.2

0.4

0.3

0.1

    Bonus Allowance

10.5

9.8

8.0

9.0

8.2

    Provision for directors'' bonuses

0.4

1.1

1.3

0.2

0.4

    Rounding adjustment Liability

0.1

-

-

-

-

    Allow. Warranty

13.7

17.0

13.5

9.6

10.1

    Reserve for settlement

-

-

-

-

0.0

    Provision for business structure improv.

-

2.3

0.0

-

-

    Other Liability

89.3

77.4

57.1

63.3

84.5

Total Current Liabilities

438.6

501.3

464.7

367.2

454.4

 

 

 

 

 

 

    Corporate Bond

116.5

130.0

123.3

107.4

110.3

    Long-term loans payable

24.6

16.8

14.7

18.6

23.5

    Fin.Lease

-

3.3

2.9

3.1

-

Total Long Term Debt

141.1

150.0

141.0

129.1

133.8

 

 

 

 

 

 

    Deferred Tax

1.8

1.4

1.4

0.3

0.1

    Allow.Accr.Retir

24.1

23.1

21.4

18.0

18.4

    Provision for directors'' retirement ben

2.3

2.9

3.1

2.7

9.9

    Provision for compensation losses

5.3

8.0

5.3

0.0

-

    Res. for guarantee oblig.(non-current)

-

0.0

0.8

0.6

0.6

    Other Long Term Liabilities

0.0

-

-

-

-

    Other Liability

19.2

17.5

17.4

14.9

5.2

    Minor. Interest

0.5

0.5

0.1

0.1

0.1

Total Liabilities

632.8

704.7

655.2

532.9

622.6

 

 

 

 

 

 

    Other Equity

0.0

-

-

-

-

    Common Stock

139.9

156.1

148.1

129.0

132.4

    Capital surplus

218.0

243.3

230.8

201.1

206.4

    Retained earnings

835.3

861.4

720.9

548.8

546.5

    Treasure Stock

-9.1

-10.2

-9.9

-8.7

-8.9

    Valuation difference on available-for-sa

11.5

9.3

11.1

10.0

5.1

    Foreign Exchange

-39.7

-87.1

-65.0

-21.9

-34.0

    Subscription rights to shares

2.9

2.4

1.6

0.6

0.0

Total Equity

1,158.7

1,175.2

1,037.5

859.0

847.5

 

 

 

 

 

 

Total Liabilities & Shareholders' Equity

1,791.5

1,879.9

1,692.7

1,391.8

1,470.1

 

 

 

 

 

 

    S/O-Ordinary Shares

42.3

42.3

42.3

42.3

42.3

Total Common Shares Outstanding

42.3

42.3

42.3

42.3

42.3

T/S-Ordinary Shares

0.2

0.2

0.2

0.2

0.2

Full-Time Employees

5,530

5,448

5,202

5,133

5,146

Total Number of Shareholders

6,577

-

-

-

-

Number of Common Shareholders

-

7,883

7,407

7,798

8,856

Long Term Debt within 1 Year

14.2

6.9

6.6

4.9

7.2

Lns Pble Maturing over a Yr within 2 Yrs

5.5

-

-

-

-

Bond Redemp Amts over a Yr within 2 Yrs

116.5

-

-

-

-

Long Term Debt within 2 Years

-

12.1

4.4

4.6

5.2

Lns Pble Maturg over 2 Yrs within 3 Yrs

5.1

-

-

-

-

Long Term Debt within 3 Years

-

132.0

9.7

4.2

4.2

Lns Pble Maturg over 3 Yrs within 4 Yrs

3.1

-

-

-

-

Long Term Debt within 4 Years

-

1.7

0.6

9.7

4.3

Lns Pble Maturg over 4 Yrs within 5 Yrs

2.6

-

-

-

-

Long Term Debt within 5 Years

-

1.0

0.0

107.4

9.8

Other Division And End Of Current Period

8.3

-

-

-

-

Long Term Debt Remaining

-

0.0

0.0

-

110.3

Total Long Term Debt, Supplemental

155.3

153.7

21.3

130.9

141.0

Capital Lease Payments Due within 1 Year

1.9

1.7

1.5

2.8

-

Cap Lease Maturg over a Yr within 2 Yrs

1.5

-

-

-

-

Capital Lease Payments Due within 2 Year

-

1.5

1.2

1.2

-

Cap Lease Maturg over 2 Yr within 3 Yrs

1.0

-

-

-

-

Capital Lease Payments Due within 3 Year

-

1.0

1.1

0.8

-

Cap Lease Maturg over 3 Yr within 4 Yrs

0.7

-

-

-

-

Capital Lease Payments Due within 4 Year

-

0.5

0.5

0.8

-

Cap Lease Maturg over 4 Yr within 5 Yrs

0.1

-

-

-

-

Capital Lease Payments Due within 5 Year

-

0.2

0.1

0.2

-

Other Division And End Of Current Period

0.0

-

-

-

-

Capital Leases - Remaining Maturities

-

0.0

0.0

0.0

-

Total Capital Leases, Supplemental

5.2

4.9

4.4

5.9

-

Pension Obligation

74.9

75.8

67.9

56.4

53.5

Fair Value of Plan Assets

49.4

42.6

36.5

27.5

22.6

Funded Status

-25.5

-33.1

-31.4

-28.9

-30.8

Total Funded Status

-25.5

-33.1

-31.4

-28.9

-30.8

Discount Rate

2.00%

2.00%

2.00%

2.00%

2.00%

Expected Return on Plan Assets

1.50%

1.50%

1.50%

2.00%

2.00%

Unrecognized Actuarial Gains & Losses

0.0

7.0

5.7

5.9

5.9

Unrecognized Prior Service Cost

1.4

3.1

4.3

5.0

6.4

Accrued Pension Benefit

-24.1

-15.3

-21.4

-18.0

-18.4

Net Assets Recognized on Balance Sheet

-22.6

-5.2

-11.3

-7.1

-6.1

 


Annual Cash Flows

 

Financials in: USD (mil)

 

 

 

 

31-Dec-2012

31-Dec-2011

31-Dec-2010

31-Dec-2009

31-Dec-2008

Period Length

12 Months

12 Months

12 Months

12 Months

12 Months

UpdateType/Date

Updated Normal 
31-Dec-2012

Updated Normal 
31-Dec-2011

Updated Normal 
31-Dec-2010

Updated Normal 
31-Dec-2009

Updated Normal 
31-Dec-2008

Filed Currency

JPY

JPY

JPY

JPY

JPY

Exchange Rate (Period Average)

79.797487

79.698224

87.789317

93.619712

103.395546

Auditor

KPMG AZSA LLC

KPMG LLP

KPMG LLP

KPMG LLP

KPMG LLP

Auditor Opinion

Unqualified

Unqualified

Unqualified

Unqualified with Explanation

Unqualified

 

 

 

 

 

 

Income before income taxes

140.0

171.2

135.3

46.9

96.5

    Depreciation

45.7

51.6

51.1

48.5

43.5

    Impairment Loss

1.7

1.2

0.5

2.5

4.5

    Amort. Goodwill

1.2

0.4

0.4

0.4

4.4

    Increase (decrease) in allowance for dou

0.7

-0.5

1.9

3.0

-0.3

    Increase (decrease) in provision for bus

-2.2

2.4

0.0

-

-

    Reserve for settlement

-

-

-

0.0

-11.6

    Inc/Dec Provision For Retirement Benefit

2.3

1.1

2.2

0.5

1.5

    Increase (decrease) in provision for dir

-0.3

-0.3

-0.1

-6.8

2.0

    Increase (decrease) in provision for los

0.0

-0.8

0.0

-

-

    Increase (decrease) in provision for com

-2.0

2.3

4.9

0.0

-

    Reserve for loss on guarantees

-

-

-

-

0.0

    Interest & Dividend

-3.9

-2.4

-2.1

-2.5

-4.3

    Interest Expenses

6.0

6.2

5.6

7.1

8.6

    Foreign exchange losses (gains)

0.2

-0.3

0.7

0.4

-0.1

    Bond Issue Cost

-

-

-

-

0.0

    Loss (gain) on sales of noncurrent asset

-0.4

-0.1

-3.3

0.0

-0.3

    Write Off Fixed Assets

1.8

0.6

1.3

0.4

0.9

    Loss-Sale PP&E

-

-

-

-

0.1

    G/L on val. of mkbl securities

-

0.0

0.0

0.0

0.0

    G/L on sale of mkbl. secs.

-

-

0.0

0.0

0.0

    L on val. of affiliated comp.

-

-

0.0

0.2

0.0

    Loss (gain) on valuation of investment s

0.0

4.6

2.3

0.1

1.8

    Loss (gain) on sales of investment secur

0.0

0.0

0.0

-0.1

0.0

    Accounting Change Loss

-

-

-

-

0.0

    Decrease (increase) in notes and account

51.8

-51.2

-56.8

38.2

27.7

    Decrease (increase) in inventories

0.5

-26.9

-42.0

72.0

-2.6

    Increase (decrease) in notes and account

-29.4

0.9

44.8

-8.2

-24.2

    Other Operating Cash Flow

0.0

-

-

-

-

    Other, net

17.8

9.9

6.1

-22.9

-8.6

    Int.&Divid. Received

3.8

2.3

2.2

2.7

4.4

    Interest Paid

-6.3

-6.5

-5.7

-7.5

-8.1

    Income taxes (paid) refund

-61.1

-78.7

-13.0

-28.4

-62.8

    Adjustment

-

-

-

-

-0.1

Cash from Operating Activities

167.9

87.2

136.2

146.4

72.7

 

 

 

 

 

 

    Time Deposit Made

-30.2

-10.9

-7.5

-1.6

0.0

    Proceeds From Withdrawal Of Time Deposit

0.4

-

-

-

-

    Proceeds from sales and redemption of se

31.4

-

-

-

-

    Time Deposit Matured

30.2

6.4

9.2

0.0

72.7

    Derivative deposit made

-

0.0

-3.0

0.0

0.0

    Proceeds From Withdrawal Of Time Deposit

-

0.4

0.0

7.5

-

    Purchase of short-term investment securi

-36.4

-23.9

-2.6

-3.5

0.0

    Sale Mktbl. Secs.

-

11.4

5.2

1.1

0.0

    Purchase of property, plant and equipmen

-84.5

-52.7

-37.4

-42.1

-46.4

    Purch. Inv. Secs.

-1.8

-1.7

-1.2

-2.3

-10.0

    Sale Inv. Secs.

0.1

0.2

1.0

0.3

0.2

    Proceeds from sales of property, plant a

1.0

0.6

6.9

3.0

2.2

    Purch. Intangible

-8.9

-2.8

-2.1

-5.2

-13.8

    Change in Consoli.-Purch.Subsid Stk.

-

-

0.0

-1.3

0.0

    Purchase of subsidiaries' securities

-0.2

-0.6

0.0

-

-

    Loan Made

-1.8

-1.2

-0.9

0.0

0.0

    Loan Collected

1.1

0.4

0.3

0.0

0.1

    Rounding adjustment Cash flow

0.0

-

-

-

-

    Other, net

0.7

-2.5

-0.1

-0.7

-0.3

Cash from Investing Activities

-98.9

-77.1

-32.1

-44.8

4.8

 

 

 

 

 

 

    Net decrease (increase) in treasury stoc

0.0

-

-

-

-

    Redemption of Corp. Bond

-

-

-

0.0

-48.4

    Net increase (decrease) in short-term lo

-30.0

19.5

-0.4

-23.0

33.7

    Proceeds from long-term loans payable

22.9

10.3

3.9

0.2

8.7

    Repayment of long-term loans payable

-8.0

-7.2

-6.2

-9.3

-7.5

    Issue Bond

-

-

-

-

0.0

    Stock Subscription Excercised

-

-

0.0

0.1

1.0

    Purch.Treasury Stock

-

-

0.0

0.0

-7.7

    Disp. Treasury Stock

-

-

-

-

0.0

    Rounding adjustment Cash flow

0.0

-

-

-

-

    Proceed from minorities' payment

0.0

0.5

0.0

-

-

    Dividend Paid

-24.3

-10.6

-6.3

-15.8

-18.0

    Divid Paid to Minor.

0.0

-0.1

0.0

-

-

    Repayment of finance lease

-2.0

-1.7

-2.7

-2.5

0.0

    Other

-

-

-

0.0

0.0

Cash from Financing Activities

-41.4

10.8

-11.7

-50.4

-38.1

 

 

 

 

 

 

Foreign Exchange Effects

11.2

-4.5

-14.2

1.4

-19.1

Net increase (decrease) in cash and cash

38.7

16.4

78.2

52.7

20.3

 

 

 

 

 

 

Net Cash - Beginning Balance

448.2

432.4

314.3

242.0

198.9

Net Cash - Ending Balance

487.0

448.8

392.5

294.7

219.2

    Cash Interest Paid

6.3

6.5

5.7

7.5

8.1

    Income taxes (paid) refund

61.1

78.7

13.0

28.4

62.8

 

 

Financial health  

 

Financials in: USD (mil)

Except for share items (millions) and per share items (actual units)

 

Key Indicators USD (mil)

 

Quarter
Ending
30-Sep-2013

Quarter
Ending
Yr Ago

Annual
Year End
31-Dec-2012

1 Year
Growth

3 Year
Growth

5 Year
Growth

Total Revenue1 (?)

329.4

25.91%

1,473.8

-4.74%

4.01%

-4.01%

Research & Development1 (?)

-

-

126.5

0.32%

0.88%

1.27%

Operating Income1 (?)

24.9

41.70%

144.6

-17.21%

39.38%

-4.58%

Income Available to Common Excl Extraord Items1 (?)

17.1

64.75%

92.7

-14.64%

32.76%

-3.18%

Basic EPS Excl Extraord Items1 (?)

0.40

64.73%

2.19

-14.64%

32.75%

-3.13%

Capital Expenditures2 (?)

34.1

-

93.4

68.24%

18.96%

-3.91%

Cash from Operating Activities2 (?)

65.6

-

167.9

92.71%

-0.77%

-0.27%

Free Cash Flow (?)

30.5

-

69.2

135.70%

-13.81%

5.82%

Total Assets3 (?)

1,729.0

19.99%

1,791.5

6.36%

5.89%

-0.07%

Total Liabilities3 (?)

645.4

29.49%

632.8

0.23%

3.08%

-5.98%

Total Long Term Debt3(?)

22.2

-80.33%

141.1

4.94%

0.27%

-0.84%

Employees3 (?)

-

-

5530

1.51%

2.51%

2.13%

Total Common Shares Outstanding3 (?)

42.3

0.01%

42.3

0.01%

0.01%

-0.08%

1-ExchangeRate: JPY to USD Average for Period

98.955314

 

79.797487

 

 

 

2-ExchangeRate: JPY to USD Average for Period

95.281806

 

79.797487

 

 

 

3-ExchangeRate: JPY to USD Period End Date

98.230000

 

85.870003

 

 

 

 

 

Key Ratios

 

31-Dec-2012

31-Dec-2011

31-Dec-2010

31-Dec-2009

31-Dec-2008

Profitability

Gross Margin (?)

41.99%

43.09%

44.20%

43.38%

44.38%

Operating Margin (?)

9.81%

11.29%

9.77%

4.08%

8.10%

Pretax Margin (?)

9.50%

11.05%

10.02%

4.21%

7.44%

Net Profit Margin (?)

6.29%

7.02%

6.69%

3.02%

4.50%

Financial Strength

Current Ratio (?)

2.97

2.81

2.66

2.63

2.30

Long Term Debt/Equity (?)

0.12

0.13

0.14

0.15

0.16

Total Debt/Equity (?)

0.18

0.20

0.20

0.24

0.27

Management Effectiveness

Return on Assets (?)

4.96%

6.15%

5.94%

2.41%

4.21%

Return on Equity (?)

7.79%

9.93%

9.66%

4.03%

7.68%

Efficiency

Receivables Turnover (?)

3.12

3.32

3.42

2.97

3.27

Inventory Turnover (?)

2.51

2.75

2.74

2.23

2.35

Asset Turnover (?)

0.79

0.88

0.89

0.80

0.93

 

 

Market Valuation USD (mil)

P/E (TTM) (?)

19.19

.

Enterprise Value2 (?)

1,187.5

Price/Sales (TTM) (?)

1.14

.

Enterprise Value/Revenue (TTM) (?)

0.92

Price/Book (MRQ) (?)

1.36

.

Enterprise Value/EBITDA (TTM) (?)

8.20

Market Cap as of 08-Nov-20131 (?)

1,471.2

.

 

 

1-ExchangeRate: JPY to USD on 8-Nov-2013

98.582788

 

 

 

2-ExchangeRate: JPY to USD on 30-Sep-2013

98.230000

 

 

 

 

 

Annual ratios

 

Financials in: USD (mil)

Except for share items (millions) and per share items (actual units)

 

 

 

 

31-Dec-2012

31-Dec-2011

31-Dec-2010

31-Dec-2009

31-Dec-2008

Financial Strength

Current Ratio (?)

2.97

2.81

2.66

2.63

2.30

Quick/Acid Test Ratio (?)

2.06

1.97

1.86

1.80

1.46

Working Capital1 (?)

865.6

905.7

769.7

598.5

588.9

Long Term Debt/Equity (?)

0.12

0.13

0.14

0.15

0.16

Total Debt/Equity (?)

0.18

0.20

0.20

0.24

0.27

Long Term Debt/Total Capital (?)

0.10

0.11

0.11

0.12

0.12

Total Debt/Total Capital (?)

0.15

0.17

0.17

0.19

0.21

Payout Ratio (?)

22.88%

19.53%

9.07%

17.39%

30.82%

Effective Tax Rate (?)

33.79%

36.51%

33.28%

28.04%

39.34%

Total Capital1 (?)

1,364.0

1,413.7

1,248.7

1,061.9

1,079.0

 

 

 

 

 

 

Efficiency

Asset Turnover (?)

0.79

0.88

0.89

0.80

0.93

Inventory Turnover (?)

2.51

2.75

2.74

2.23

2.35

Days In Inventory (?)

145.49

132.81

132.99

163.93

155.28

Receivables Turnover (?)

3.12

3.32

3.42

2.97

3.27

Days Receivables Outstanding (?)

116.83

109.82

106.75

123.03

111.60

Revenue/Employee2 (?)

247,670

294,526

281,000

218,764

287,784

Operating Income/Employee2 (?)

24,298

33,249

27,456

8,917

23,308

EBITDA/Employee2 (?)

31,974

33,249

38,096

18,409

32,957

 

 

 

 

 

 

Profitability

Gross Margin (?)

41.99%

43.09%

44.20%

43.38%

44.38%

Operating Margin (?)

9.81%

11.29%

9.77%

4.08%

8.10%

EBITDA Margin (?)

12.91%

11.29%

13.56%

8.42%

11.45%

EBIT Margin (?)

9.81%

11.29%

9.77%

4.08%

8.10%

Pretax Margin (?)

9.50%

11.05%

10.02%

4.21%

7.44%

Net Profit Margin (?)

6.29%

7.02%

6.69%

3.02%

4.50%

R&D Expense/Revenue (?)

8.58%

8.15%

8.00%

9.40%

7.94%

COGS/Revenue (?)

58.01%

56.91%

55.80%

56.62%

55.62%

SG&A Expense/Revenue (?)

23.42%

22.87%

25.83%

29.51%

26.48%

 

 

 

 

 

 

Management Effectiveness

Return on Assets (?)

4.96%

6.15%

5.94%

2.41%

4.21%

Return on Equity (?)

7.79%

9.93%

9.66%

4.03%

7.68%

 

 

 

 

 

 

Valuation

Free Cash Flow/Share2 (?)

1.64

0.77

2.48

2.36

0.34

Operating Cash Flow/Share 2 (?)

3.69

2.14

3.49

3.48

1.96

1-ExchangeRate: JPY to USD Period End Date

85.870003

76.94

81.105

93.095

90.65

2-ExchangeRate: JPY to USD Average for Period

85.870003

76.94

81.105

93.095

90.65

 

 

Current Market Multiples

Market Cap/Earnings (TTM) (?)

19.29

Market Cap/Equity (MRQ) (?)

1.36

Market Cap/Revenue (TTM) (?)

1.14

Market Cap/EBIT (TTM) (?)

13.02

Market Cap/EBITDA (TTM) (?)

10.20

Enterprise Value/Earnings (TTM) (?)

15.52

Enterprise Value/Equity (MRQ) (?)

1.10

Enterprise Value/Revenue (TTM) (?)

0.92

Enterprise Value/EBIT (TTM) (?)

10.47

Enterprise Value/EBITDA (TTM) (?)

8.20

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.62.34

UK Pound

1

Rs.102.06

Euro

1

Rs.84.46

 

 

INFORMATION DETAILS

 

Report Prepared by :

NNA

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.